Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PharmEng Relocates Keata CMO Ops | Contract Pharma

What are you searching for?

Sign in
Breaking News

PharmEng Relocates Keata CMO Ops

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PharmEng International‘s wholly owned subsidiary, Keata Pharma Inc., is relocating contract manufacturing operations from its Perth, Ontario facility to their its pharmaceutical manufacturing facility in Sydney, Nova Scotia. Included in the relocation from Perth are existing pharmaceutical supply contracts, manufacturing equipment and personnel.

The 46,400-sq.-ft. Sydney facility includes offices for PharmEng’s pharmaceutical consulting division, pilot laboratories for formulation development, production rooms with various capabilities such as high shear mixing, container blending and equipment for modified release technologies. The facility provides formulation development and testing services to manufacture and package products in solid and liquid dosage forms. The Sydney facility has been designed to meet all cGMP requirements, the company assures.

Keata’s long-term goal is to develop capabilities in other dosage forms, such as suppositories, topicals and injectables. The facility is located on five acres in the Northside Industrial Park, a 300 acre business park in North Sydney, NS. The transition from the Perth facility to the Sydney facility was completed at the end of May.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics